These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9378841)

  • 1. Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans.
    Kaplan GB; Greenblatt DJ; Ehrenberg BL; Goddard JE; Cotreau MM; Harmatz JS; Shader RI
    J Clin Pharmacol; 1997 Aug; 37(8):693-703. PubMed ID: 9378841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychomotor performance: investigating the dose-response relationship for caffeine and theophylline in elderly volunteers.
    Bryant CA; Farmer A; Tiplady B; Keating J; Sherwood R; Swift CG; Jackson SH
    Eur J Clin Pharmacol; 1998 Jun; 54(4):309-13. PubMed ID: 9696955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluvoxamine impairs single-dose caffeine clearance without altering caffeine pharmacodynamics.
    Culm-Merdek KE; von Moltke LL; Harmatz JS; Greenblatt DJ
    Br J Clin Pharmacol; 2005 Nov; 60(5):486-93. PubMed ID: 16236038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness.
    Killgore WD; Rupp TL; Grugle NL; Reichardt RM; Lipizzi EL; Balkin TJ
    J Sleep Res; 2008 Sep; 17(3):309-21. PubMed ID: 18522689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine.
    Cysneiros RM; Farkas D; Harmatz JS; von Moltke LL; Greenblatt DJ
    Clin Pharmacol Ther; 2007 Jul; 82(1):54-62. PubMed ID: 17443132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine.
    Wesensten NJ; Belenky G; Kautz MA; Thorne DR; Reichardt RM; Balkin TJ
    Psychopharmacology (Berl); 2002 Jan; 159(3):238-47. PubMed ID: 11862356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers.
    Jones HE; Griffiths RR
    Psychopharmacology (Berl); 2003 Jan; 165(3):280-90. PubMed ID: 12434259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced stimulant and metabolic effects of combined ephedrine and caffeine.
    Haller CA; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 2004 Apr; 75(4):259-73. PubMed ID: 15060505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midazolam 12 mg is moderately counteracted by 250 mg caffeine in man.
    Mattila MJ; Vainio P; Nurminen ML; Vanakoski J; Seppälä T
    Int J Clin Pharmacol Ther; 2000 Dec; 38(12):581-7. PubMed ID: 11125871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subjective effects of caffeine among introverts and extraverts in the morning and evening.
    Liguori A; Grass JA; Hughes JR
    Exp Clin Psychopharmacol; 1999 Aug; 7(3):244-9. PubMed ID: 10472512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine.
    Haskell CF; Kennedy DO; Wesnes KA; Scholey AB
    Psychopharmacology (Berl); 2005 Jun; 179(4):813-25. PubMed ID: 15678363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute caffeine consumption enhances the executive control of visual attention in habitual consumers.
    Brunyé TT; Mahoney CR; Lieberman HR; Giles GE; Taylor HA
    Brain Cogn; 2010 Dec; 74(3):186-92. PubMed ID: 20832925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of strategic early-morning caffeine gum administration on association between salivary alpha-amylase and neurobehavioural performance during 50 h of sleep deprivation.
    Pajcin M; White JM; Banks S; Dorrian J; Paech GM; Grant CL; Johnson K; Tooley K; Aidman E; Fidock J; Kamimori GH; Della Vedova CB
    Accid Anal Prev; 2019 May; 126():160-172. PubMed ID: 29402402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and psychomotor performance of alprazolam: concentration-effect relationship.
    Wright CE; Sisson TL; Fleishaker JC; Antal EJ
    J Clin Pharmacol; 1997 Apr; 37(4):321-9. PubMed ID: 9115058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of caffeine on mood and performance: a study of realistic consumption.
    Brice CF; Smith AP
    Psychopharmacology (Berl); 2002 Nov; 164(2):188-92. PubMed ID: 12404081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of caffeine, sleep loss, and stress on cognitive performance and mood during U.S. Navy SEAL training. Sea-Air-Land.
    Lieberman HR; Tharion WJ; Shukitt-Hale B; Speckman KL; Tulley R
    Psychopharmacology (Berl); 2002 Nov; 164(3):250-61. PubMed ID: 12424548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers.
    Garrett BE; Griffiths RR
    J Pharmacol Exp Ther; 2001 Feb; 296(2):486-94. PubMed ID: 11160635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of placebo awareness on stimulant drug response in a double-blind trial.
    Nash JM; Holroyd KA; Rokicki LA; Kvaal S; Penzien DB
    Psychopharmacology (Berl); 2002 May; 161(3):213-21. PubMed ID: 12021824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose repeated caffeine administration for circadian-phase-dependent performance degradation during extended wakefulness.
    Wyatt JK; Cajochen C; Ritz-De Cecco A; Czeisler CA; Dijk DJ
    Sleep; 2004 May; 27(3):374-81. PubMed ID: 15164887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of caffeine on visual evoked potential (P300) and neuromotor performance.
    Deslandes AC; Veiga H; Cagy M; Piedade R; Pompeu F; Ribeiro P
    Arq Neuropsiquiatr; 2004 Jun; 62(2B):385-90. PubMed ID: 15273831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.